Eli Lilly forecasts $45 billion revenue for 2024, 32% higher than last year. Medicare changes and stocking issues impact the revised guidance.

EY—the professional services firm originally known as Ernst & Young—reports the dollar value of biopharma M&A deals nosedived ...

"We had three kids in day care at the same time," Almond said, noting the cost can often be a burden for many families.

As 2025 begins, the Independent Tribune has talked to several community leaders about accomplishments for 2024, challenges, ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the other healthcare stocks Jim Cramer has made bold predictions about. Healthcare has been ...

As the 250th anniversary of the battles of Lexington and Concord nears, planning for this once-in-a-generation celebration includes a sprawling array of parades, reenactments, tributes — and ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

Both Eli Lilly and Novo Nordisk have invested in GLP-1 injectables manufacturing sites, with more capacity on the way. With a ribbon-cutting ceremony and tour on June 14, 2024, Lilly showed off its ...

Eli Lilly (LLY) closed at $795.67 in the latest trading session, marking a -0.08% move from the prior day. The stock's performance was behind the S&P 500's daily gain of 1.1%. Elsewhere ...